Share on Facebook Share on Twitter Email
Answers.com

Fenfluramine

 
Food and Nutrition: fenfluramine
 

Anorectic drug formerly used in the treatment of obesity, withdrawn in 1995 because of reports of heart valve damage.

Search unanswered questions...
Enter a word or phrase...
All Community Q&A Reference topics
Food and Fitness: fenfluramine
 

An appetite suppressant, chemically related to amphetamine, but without its addictive properties. Fenfluramine is used in the treatment of obesity. Adverse side-effects include depression and irregular heart beats.

 
Drug Info: Fenfluramine
Top

Brand names: Pondimin®

Chemical formula:



Last updated: 7/1/2002

Important Disclaimer: The drug information provided here is for educational purposes only. It is intended to supplement, not substitute for, the diagnosis, treatment and advice of a medical professional. This drug information does not cover all possible uses, precautions, side effects and interactions. It should not be construed to indicate that this or any drug is safe for you. Consult your medical professional for guidance before using any prescription or over the counter drugs.

 
Medical Dictionary: fen·flu·ra·mine
Top
(fĕn-flʊr'ə-mēn')
n.

A fluorinated compound that is used in the treatment of refractory obesity.

 
Wikipedia: Fenfluramine
Top
Fenfluramine
Systematic (IUPAC) name
N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine
Identifiers
CAS number 458-24-2
ATC code A08AA02
PubChem 3337
DrugBank APRD00319
Chemical data
Formula C12H16F3N 
Mol. mass 231.257
Pharmacokinetic data
Bioavailability  ?
Metabolism Hepatic
Half life 20 hours
Excretion Renal
Therapeutic considerations
Pregnancy cat.

?

Legal status

Schedule IV(US) Withdrawn from market

Routes Oral

Fenfluramine is a drug that was part of the Fen-Phen anti-obesity medication (the other drug being phentermine). Also known as Pondimin, fenfluramine was introduced on the U.S. market in 1973. It is the racemic mixture of two enantiomers, dextrofenfluramine and levofenfluramine. It increases the level of the neurotransmitter serotonin, a chemical that regulates mood, appetite and other functions. Fenfluramine causes the release of serotonin by disrupting vesicular storage of the neurotransmitter, and reversing serotonin transporter function.[1] The end result is a feeling of fullness and loss of appetite.

Contents

Withdrawal due to heart disease

The drug was withdrawn from the U.S. market in 1997 after reports of heart valve disease,[2][3] and pulmonary hypertension, including a condition known as cardiac fibrosis. After the US withdrawal of fenfluramine, it was also withdrawn from other markets around the world.

The distinctive valvular abnormality seen with fenfluramine is a thickening of the leaflet and chordae tendineae. One mechanisms used to explain this phenomenon involves heart valve serotonin receptors, which are thought to help regulate growth. Since fenfluramine and its active metabolite norfenfluramine stimulate serotonin receptors 5-hydroxytryptamine (5-HT) this may have led to the valvular abnormalities found in patients using fenfluramine. In particular norfenfluramine is a potent agonist of 5-HT2B receptors, which are plentiful in human cardiac valves. The suggested mechanism by which fenfluramine causes damage is through over or inappropriate stimulation of these receptors leading to inappropriate valve cell division. Supporting this idea, is the fact that this valve abnormality has also occurred in patients using other drugs that act on 5-HT2B receptors. [4].

According to a study of 5743 former users, damage to the heart valve continued long after stopping the medication [5]. Of the users tested, 20 percent of women, and 12 percent of men were affected. For all ex-users, there was a seven fold increase of chances of needing surgery for faulty heart valves caused by the drug.

References

  1. ^ Nestler, Eric J. "Molecular Neuropharmacology: A Foundation for Clinical Neuroscience" McGraw-Hill, 2001.
  2. ^ Connolly HM, Crary JL, McGoon MD, et al (1997). "Valvular heart disease associated with fenfluramine-phentermine". N. Engl. J. Med. 337 (9): 581–8. doi:10.1056/NEJM199708283370901. PMID 9271479. http://content.nejm.org/cgi/content/full/337/9/581. 
  3. ^ Weissman NJ (2001). "Appetite suppressants and valvular heart disease". Am. J. Med. Sci. 321 (4): 285–91. doi:10.1097/00000441-200104000-00008. PMID 11307869. 
  4. ^ Roth BL (2007). "Drugs and valvular heart disease". N. Engl. J. Med. 356 (1): 6–9. doi:10.1056/NEJMp068265. PMID 17202450. 
  5. ^ Dahl CF, Allen MR, Urie PM, Hopkins PN (2008). "Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals". BMC Med 6: 34. doi:10.1186/1741-7015-6-34. PMID 18990200. 

Further reading

  • Welch JT, Lim DS (November 2007). "The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine". Bioorg. Med. Chem. 15 (21): 6659–66. doi:10.1016/j.bmc.2007.08.012. PMID 17765553. 

External links


 
 

 

Copyrights:

Food and Nutrition. A Dictionary of Food and Nutrition. Copyright © 1995, 2003, 2005 by A. E. Bender and D. A. Bender. All rights reserved.  Read more
Food and Fitness. Food and Fitness: A Dictionary of Diet and Exercise. Copyright © 1997, 2003 by Oxford University Press. All rights reserved.  Read more
Drug Info. Gold Standard. Copyright © 2008 by Gold Standard. All rights reserved.  Read more
Medical Dictionary. The American Heritage® Stedman's Medical Dictionary Copyright © 2002, 2001, 1995 by Houghton Mifflin Company Read more
Wikipedia. This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Fenfluramine" Read more